Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells

Keyphrases

• Antiviral Activity 100%
• Respiratory Syncytial Virus 100%
• Airway Epithelial Cells 100%
• Extracellular Vesicles 100%
• Interferon-α (IFN-α) 60%
• Nasopharyngeal Secretion 20%
• Virus-infected Cell 20%
• Viral Replication 13%
• Viral Infection 13%
• Innate Immune Response 13%
• Chemokines 13%
• Cargo 13%
• Recipient Cells 13%
• Receptor Signaling 6%
• Infected Cells 6%
• Virus Replication 6%
• Airway 6%
• Cellular Response 6%
• RNA-DNA 6%
• RNA-protein Complex 6%
• Potential Therapeutics 6%
• Novel Antivirals 6%
• Acute Lower Respiratory Tract Infection 6%
• Antiviral Genes 6%
• Effective Treatment 6%
• Interferon Receptor 6%
• A549 Cells 6%
• Immune Mediators 6%
• Significant Level 6%
• Human Monocytes 6%
• Microvesicles 6%
• Human Airways 6%
• Subsequent Infection 6%
• Signal Transduction Inhibitors 6%
• Cerdulatinib 6%
• Extracellular Vesicle Cargo 6%
• Respiratory Tract Infection in children 6%
• Biologically Active Substances 6%

Immunology and Microbiology

• Antiviral Activity 100%
• Human Respiratory Syncytial Virus 100%
• Airway 100%
• interferon 61%
• Secretion (Process) 23%
• Viral Disease 15%
• Cytokine 15%
• Viral Replication 15%
• Chemokine 15%
• Infectious Disease 15%
• Infection 15%
• Innate Immune System 7%
• Monocyte 7%
• Mediator 7%
• Lower Respiratory Tract 7%
• Viral Replication 7%
• DNA RNA Hybridization 7%
• Interferon Type III 7%
• Interferon Type I 7%
• Pretreatment 7%